Traders sold shares of UnitedHealth Group Inc (NYSE:UNH) on strength during trading on Tuesday following insider selling activity. $146.91 million flowed into the stock on the tick-up and $243.85 million flowed out of the stock on the tick-down, for a money net flow of $96.94 million out of the stock. Of all stocks tracked, UnitedHealth Group had the 8th highest net out-flow for the day. UnitedHealth Group traded up $1.65 for the day and closed at $245.21Specifically, Director Kenneth Irwin Shine sold 457 shares of UnitedHealth Group stock in a transaction dated Tuesday, November 14th. The shares were sold at an average price of $211.03, for a total transaction of $96,440.71. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Gail R. Wilensky sold 5,600 shares of UnitedHealth Group stock in a transaction dated Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the transaction, the director now directly owns 61,137 shares of the company’s stock, valued at $13,652,503.47. The disclosure for this sale can be found here. Insiders have sold a total of 33,853 shares of company stock valued at $7,517,108 over the last three months. 0.89% of the stock is currently owned by insiders.

UNH has been the subject of several analyst reports. Credit Suisse Group reissued a “buy” rating on shares of UnitedHealth Group in a report on Wednesday, December 27th. Cantor Fitzgerald lifted their price target on shares of UnitedHealth Group to $225.00 and gave the company an “overweight” rating in a report on Wednesday, October 18th. Wells Fargo & Co restated an “outperform” rating and issued a $245.00 price objective (up previously from $230.00) on shares of UnitedHealth Group in a research report on Wednesday, November 29th. ValuEngine cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, December 7th. Finally, Goldman Sachs Group initiated coverage on shares of UnitedHealth Group in a research report on Wednesday, January 3rd. They issued a “buy” rating and a $269.00 price objective for the company. Two analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the company’s stock. UnitedHealth Group has a consensus rating of “Buy” and a consensus price target of $243.22.

The company has a debt-to-equity ratio of 0.58, a current ratio of 0.73 and a quick ratio of 0.70. The stock has a market cap of $237,080.00, a PE ratio of 22.90, a P/E/G ratio of 1.42 and a beta of 0.66.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, topping the consensus estimate of $2.50 by $0.09. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The company had revenue of $52.06 billion during the quarter, compared to analysts’ expectations of $51.57 billion. During the same quarter in the previous year, the company earned $2.11 EPS. UnitedHealth Group’s revenue was up 9.5% on a year-over-year basis. equities research analysts predict that UnitedHealth Group Inc will post 12.52 earnings per share for the current year.

Large investors have recently modified their holdings of the company. CHICAGO TRUST Co NA grew its holdings in UnitedHealth Group by 342.1% during the second quarter. CHICAGO TRUST Co NA now owns 15,740 shares of the healthcare conglomerate’s stock valued at $2,918,000 after purchasing an additional 12,180 shares during the period. Trust Co. of Vermont grew its holdings in UnitedHealth Group by 15.2% during the second quarter. Trust Co. of Vermont now owns 6,974 shares of the healthcare conglomerate’s stock valued at $1,293,000 after purchasing an additional 922 shares during the period. Cullinan Associates Inc. grew its holdings in UnitedHealth Group by 3.6% during the second quarter. Cullinan Associates Inc. now owns 27,125 shares of the healthcare conglomerate’s stock valued at $5,030,000 after purchasing an additional 945 shares during the period. Fisher Asset Management LLC grew its holdings in UnitedHealth Group by 20.0% during the second quarter. Fisher Asset Management LLC now owns 7,699 shares of the healthcare conglomerate’s stock valued at $1,428,000 after purchasing an additional 1,285 shares during the period. Finally, State of Alaska Department of Revenue grew its holdings in UnitedHealth Group by 14.9% during the second quarter. State of Alaska Department of Revenue now owns 3,426 shares of the healthcare conglomerate’s stock valued at $635,000 after purchasing an additional 445 shares during the period. Institutional investors own 86.11% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Traders Sell UnitedHealth Group (UNH) on Strength After Insider Selling” was first posted by Daily Political and is the property of of Daily Political. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of United States and international trademark and copyright law. The correct version of this piece of content can be read at https://www.dailypolitical.com/2018/01/23/traders-sell-unitedhealth-group-unh-on-strength-after-insider-selling.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.